M&A Deal Summary |
|
|---|---|
| Date | 2010-12-16 |
| Target | Xoft |
| Sector | Medical Products |
| Buyer(s) | iCAD |
| Sellers(s) | Easton Capital Investment Group |
| Deal Type | Add-on Acquisition |
| Deal Value | 13M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1984 |
| Sector | Medical Products |
| Employees | 67 |
| Revenue | 17M USD (2023) |
iCAD is a provider of advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable Computer-Aided Detection (CAD) systems and workflow solutions for mammography (film-based, digital radiography and computed radiography), iCAD was founded in 1984 and is based in Nashua, New Hampshire.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 4 |
| Sector (Medical Products) | 1 of 3 |
| Type (Add-on Acquisition) | 1 of 3 |
| State (California) | 1 of 3 |
| Country (United States) | 1 of 4 |
| Year (2010) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-07-15 |
DermEbx
San Jose, California, United States DermEbx is a healthcare services and technology company dedicated to offering skin electronic brachytherapy programs to dermatology and oncology networks. This program includes collaboration with clinical care teams and management staff in successfully integrating equipment and software into a patient-centric workflow model. DermEbx helps its customers with scalability and operational efficiencies in delivering programs that meet quality and standards for improving patient care. |
Buy | - |
| Category | Venture Capital Firm |
|---|---|
| Founded | 2000 |
| PE ASSETS | 200M USD |
| Size | Small |
| Type | Sector Focused |
Easton Capital Investment Group is a private investment firm that targets early-stage venture capital to later-stage growth capital investments. Easton will consider opportunities across a range of industries but generally invests in the healthcare industry, including biopharmaceuticals, drug delivery, medical devices, and healthcare services. Easton looks to commit $0.50 to $10 million per transaction. Easton Capital was formed in 2000 and is based in New York.
| DEAL STATS | # |
|---|---|
| Overall | 13 of 20 |
| Sector (Medical Products) | 3 of 3 |
| Type (Add-on Acquisition) | 7 of 9 |
| State (California) | 4 of 6 |
| Country (United States) | 13 of 20 |
| Year (2010) | 1 of 1 |
| Size (of disclosed) | 6 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-03-16 |
Promedior
Lexington, Massachusetts, United States Promedior, Inc. is a clinical-stage biotechnology company pioneering the development of targeted therapeutics to treat diseases involving fibrosis. Fibrosis is a harmful process that occurs in many diseases, when normal healthy tissue is replaced with scar tissue, compromising function and ultimately leading to organ failure. Promedior focused on rare fibrotic diseases, including idiopathic pulmonary fibrosis and myelofibrosis. Promedior, Inc. was founded in 2006 and is based in Lexington, Massachusetts. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-02-09 |
PlaySpan
Santa Clara, California, United States PlaySpan is the game industry's first publisher-sponsored in-game commerce network. PlaySpan's in-game search, commerce and micropayment technologies enables game publishers and developers to generate new revenues, acquire new users and extend the loyalty of existing users. PlaySpan is based in Silicon Valley. |
Sell | $190M |
